135 related articles for article (PubMed ID: 10749324)
1. Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis model.
Alexandrakis MG; Moschandrea JA; Koulocheri SA; Kouroumalis E; Eliopoulos GD
Dig Dis Sci; 2000 Mar; 45(3):500-8. PubMed ID: 10749324
[TBL] [Abstract][Full Text] [Related]
2. Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascites.
Alexandrakis MG; Moschandrea J; Kyriakou DS; Alexandraki R; Kouroumalis E
Int J Biol Markers; 2001; 16(1):45-9. PubMed ID: 11288954
[TBL] [Abstract][Full Text] [Related]
3. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.
Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL
NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245
[TBL] [Abstract][Full Text] [Related]
4. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lectin pathway molecules and complement proteins in ascitic fluid and blood in patients with liver cirrhosis.
Glargaard S; Boysen T; Pilely K; Garred P; Ytting H
Scand J Gastroenterol; 2018 Jan; 53(1):64-69. PubMed ID: 28982257
[TBL] [Abstract][Full Text] [Related]
6. Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.
Yildirim B; Sari R; Isci N
J Natl Med Assoc; 2005 Feb; 97(2):276-80. PubMed ID: 15712792
[TBL] [Abstract][Full Text] [Related]
7. Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence.
Gerbes AL; Jüngst D; Xie YN; Permanetter W; Paumgartner G
Cancer; 1991 Oct; 68(8):1808-14. PubMed ID: 1913524
[TBL] [Abstract][Full Text] [Related]
8. Complement and immunoglobulin levels in serum and ascitic fluid of patients with spontaneous bacterial peritonitis, malignant ascites, and tuberculous peritonitis.
Yildirim B; Sezgin N; Sari R; Sevinc A; Hilmioglu F
South Med J; 2002 Oct; 95(10):1158-62. PubMed ID: 12425501
[TBL] [Abstract][Full Text] [Related]
9. Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites.
Kountouras J; Boura P; Tsapas G; Charisis K; Magoula I; Tsakiri I
Anticancer Res; 1993; 13(6B):2441-5. PubMed ID: 8135481
[TBL] [Abstract][Full Text] [Related]
10. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
[TBL] [Abstract][Full Text] [Related]
11. Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.
Zeimet AG; Widschwendter M; Knabbe C; Fuchs D; Herold M; Müller-Holzner E; Daxenbichler G; Offner FA; Dapunt O; Marth C
J Clin Oncol; 1998 May; 16(5):1861-8. PubMed ID: 9586902
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection.
Kiyici M; Nak SG; Budak F; Gurel S; Oral B; Dolar E; Gulten M
J Gastroenterol Hepatol; 2006 Jun; 21(6):963-9. PubMed ID: 16724979
[TBL] [Abstract][Full Text] [Related]
13. Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics.
Lu CW; Wang SS; Lee SD; Tsai YT; Lee FY; Shiesh SC; Wu SL; Lu RH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):350-6. PubMed ID: 1649678
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
15. Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt?
Tuzun Y; Celik Y; Bayan K; Yilmaz S; Dursun M; Canoruc F
J Int Med Res; 2009; 37(1):79-86. PubMed ID: 19215676
[TBL] [Abstract][Full Text] [Related]
16. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
17. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic of ascites due to portal hypertension: accuracy of the serum-ascites albumin gradient and protein analises in ascitic fluid].
Rodríguez Vargas BO; Monge Salgado E; Montes Teves P; Salazar Ventura S; Guzmán Calderón E
Rev Gastroenterol Peru; 2014; 34(1):23-8. PubMed ID: 24721954
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic paracentesis. A two-step approach.
Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing ascitic etiology on a biochemical basis.
Bansal S; Kaur K; Bansal AK
Hepatogastroenterology; 1998; 45(23):1673-7. PubMed ID: 9840127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
